Translate this page into:
Letter to the Editor
doi:
10.4103/sajc.sajc_25_19
Immunotherapy-induced acute pulmonary thromboembolism: A case report
1
Department of Medical Oncology, Max Institute of Cancer Care, Shalimar Bagh, Delhi, India
2
Department of Medical Oncology, Max-Super Speciality Hospital, Shalimar Bagh, Delhi, India
*Corresponding author: Dr. Waseem Abbas. drabbasdoc@gmail.com
MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Disclaimer:
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
Acknowledgments
We are thankful to our coordinators with their support this work was not possible without their support (Neha Goel, Mansi Jain, Virender).
References
- Huang AC, Postow MA, Orlowski RJ, Mick R, Bengsch B, Manne S, et al. T-cell invigoration to tumour burden ratio associated with anti-PD-1 response. Nature 2017;545:60-5.
- Johnson DB, Balko JM, Compton ML, Chalkias S, Gorham J, Xu Y, et al. Fulminant myocarditis with combination immune checkpoint blockade. N Engl J Med 2016;375:1749-55.
- Tsukamoto J, Monteiro M, Vale S, Lemos C, Scarpelli T, Carvalho L, et al. Thromboembolic events related to treatment with checkpoint inhibitors: Report of two cases. Case Rep Oncol 2018;11:648-53.
- Boutros C, Scoazec JY, Mateus C, Routier E, Roy S, Robert C, et al. Arterial thrombosis and anti-PD-1 blockade. Eur J Cancer 2018;91:164-6.
- Ibrahimi S, Machiorlatti M, Vesely SK, Malla M. Incidence of vascular thromboembolic events in patients receiving immunotherapy: A single institution experience. Blood 2017;130:4864.
- Fournel L, Arrondeau J, Boudou-Rouquette P, Girault F, Revel MP. Effect of nivolumab therapy on pulmonary artery. J Clin Oncol 2017;35 Suppl 15.
- Kunimasa K, Nishino K, Kimura M, Inoue T, Tamiya M, Kumagai T, et al. Pembrolizumab-induced acute thrombosis: A case report. Medicine (Baltimore) 2018;97:e10772.
- Haddad TC, Greeno EW. Chemotherapy-induced thrombosis. Thromb Res 2006;118:555-68.
- Varki A. Trousseau's syndrome: Multiple definitions and multiple mechanisms. Blood 2007;110:1723-9.